AN2 Therapeutics Inc — 貸借対照表 (NASDAQ:ANTX) | MetaTrader

チャート全体を表示

Financials

概要明細書統計配当金

総資産 102.56 M138.74 M92.09 M61.95 M 負債合計 7.19 M14.04 M10.24 M8.89 M 純資産合計 95.37 M124.7 M81.85 M53.06 M 負債および純資産合計 102.56 M138.74 M92.09 M61.95 M 有利子負債合計 ———— 純負債 ————

ニュース

AN2 Therapeutics Stock Cools Off After 90% Rally - AN2 Therapeutics (NASDAQ:ANTX)

AN2 Therapeutics Stock Jumps 90% Monday: What's Driving The Action? - AN2 Therapeutics (NASDAQ:ANTX)

AN2 Therapeutics raises $40M in private placement

AN2 Therapeutics、真性多血症患者対象のepetraborole第2相試験を計画

AN2 Therapeutics plans phase 2 trial of epetraborole in PV

AN2セラピューティクス、サラ・ウィリアムズを主任会計責任者に任命

AN2 Therapeutics appoints Sarah Williams as principal accounting officer

FDA clears IND for epetraborole trial in mycobacterium abscessus

AN2 Therapeutics (ANTX) Upgraded to Buy: What Does It Mean for the Stock?

Are Medical Stocks Lagging Allogene Therapeutics (ALLO) This Year?

AN2セラピューティクス（ANTX）：CFOのデイ氏が8,883ドル相当の株式を売却

An2 therapeutics (ANTX): cfo Day sells $8883 in shares